S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
NYSE:MDT

Medtronic (MDT) Stock Forecast, Price & News

$78.35
-0.34 (-0.43%)
(As of 09/29/2023 ET)
Compare
Today's Range
$77.84
▼
$80.31
50-Day Range
$78.26
▼
$90.40
52-Week Range
$75.76
▼
$92.02
Volume
6.31 million shs
Average Volume
5.69 million shs
Market Capitalization
$104.25 billion
P/E Ratio
28.91
Dividend Yield
3.52%
Price Target
$91.67
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Medtronic MarketRank™ Forecast

Analyst Rating
Hold
2.36 Rating Score
Upside/​Downside
17.0% Upside
$91.67 Price Target
Short Interest
Healthy
0.57% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.10
Upright™ Environmental Score
News Sentiment
1.34mentions of Medtronic in the last 14 days
Based on 14 Articles This Week
Insider Trading
Selling Shares
$1.69 M Sold Last Quarter
Proj. Earnings Growth
6.64%
From $5.12 to $5.46 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.05 out of 5 stars

Medical Sector

27th out of 973 stocks

Electromedical Equipment Industry

1st out of 20 stocks

See Top Rated MarketRank™ Stocks Here

MDT stock logo

About Medtronic (NYSE:MDT) Stock

Medtronic PLC is a world-leading medical technology company that develops and manufactures device-based medical therapies to improve patient outcomes. Founded in 1949 in Minneapolis, Minnesota, Medtronic has grown to become one of the largest medical device companies in the world. The company's operational and executive headquarters are in Dublin, Ireland, with over 90,000 employees in more than 150 countries.

Medtronic's portfolio of medical technologies includes products for diagnosing, treating and managing cardiac rhythm disorders and cardiovascular disease, spinal and biologics, diabetes management and neuromodulation. The company's cardiac and vascular group is the oldest and largest business unit, which develops pacemakers, defibrillators and heart valves. Medtronic's spinal and biologics business is the second-largest business unit and produces a range of implants, instruments and services to treat spinal disorders. The diabetes group develops insulin pumps, continuous glucose monitoring systems and consumables. At the same time, the neuromodulation business focuses on therapies to treat chronic pain, movement disorders and other neurological conditions.

In 2015, Medtronic acquired Covidien PLC, an Irish-based medical technology company, and moved its legal headquarters to Ireland. This transaction was the most significant U.S. corporate tax inversion in history and allowed the company to take advantage of lower corporate taxes in Ireland. The company also achieved a 100% gender and ethnically diverse pay equity in the U.S. and 99% gender pay equity globally, as reported in its Global Inclusion, Diversity and Equity 2022 annual report. Medtronic joined the Bloomberg Gender-Equality Index (GEI) in 2023, becoming one of the 483 companies listed in the index. 

Medtronic's stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol MDT and is a member of the S&P 500 and the Dow Jones Industrial Average (DJIA). The company has had several recent recalls, including the HeartWare Ventricular Assist Device in February 2021 and the controller ports in June 2021. 

Medtronic has continued to focus on developing its medical technology portfolio and announced several acquisitions and partnerships in 2021. In January, the company announced its intention to acquire Affera, Inc., Stimgenics LLC and Medicrea. In May, Medtronic announced a strategic partnership with CathWorks, and in March 2022, a contract with Vizient. The company is also working with GE Healthcare to support the needs and care demands at Ambulatory Surgery Centers in April 2022. In October 2022, Medtronic announced its intention to pursue a separation of the company's combined patient monitoring and respiratory interventions businesses. 

Medtronic PLC is a world-leading medical technology company that has grown to become one of the largest medical device companies in the world. With its portfolio of medical technologies and recent acquisitions and partnerships, the company is well-positioned to capitalize on the growth of the medical device industry. The company's commitment to gender and ethnic pay equity and inclusion and its strategic partnerships and acquisitions make Medtronic PLC an attractive option for investors looking for a long-term growth opportunity.

MDT Price History

MDT Stock News Headlines

September 26, 2023 | marketbeat.com
Clorox Pullback Presents a Chance to Clean Up on a 3.6% Dividend (MDT)
The Clorox Company's 44% two-year plunge has created an opportunity to own a defensive stock with a shiny 3.6% dividend.
September 18, 2023 | marketbeat.com
Can These 3 Healthcare Dividend Stocks Deliver Income Growth? (MDT)
Healthcare-sector dividend payers Pfizer, Medtronic, and Gilead all boosted shareholder payouts and trade at low multiples relative to potential price gains.
September 29, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
September 11, 2023 | marketbeat.com
16 Top Robotics Companies to Get to Know in 2023 (MDT)
What are the top robotics companies in the USA, as robotics continues to grow? Learn more about the best companies today with MarketBeat.
September 6, 2023 | marketbeat.com
These 5 Dividend Aristocrats are Quality Stocks for AI Investing (MDT)
Dividend investors have no fear! There is ample exposure to AI among the Dividend Aristocrats - a group well known for dividend reliability.
August 30, 2023 | marketbeat.com
A Significant Reversal is in Sight for These 5 Med Tech Companies (MDT)
Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand.
August 29, 2023 | marketbeat.com
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M (MDT)
3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up
September 29, 2023 | ca.investing.com
Carlyle in Advanced Talks for Medtronic Units Deal Valued Over $7B
September 29, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
September 29, 2023 | finance.yahoo.com
Medtronic reportedly in exclusive talks with Carlyle over patient-monitoring, respiratory intervention units
September 29, 2023 | seekingalpha.com
Unveiling Medtronic: The Hidden Gem Among Dividend Aristocrats
September 29, 2023 | msn.com
If You'd Invested $10,000 in Medtronic 10 Years Ago, This Is How Much You Would Have Today
September 27, 2023 | seekingalpha.com
Medtronic: Potential For High Growth If They Execute
September 27, 2023 | seekingalpha.com
Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
September 26, 2023 | finance.yahoo.com
15 Best Dividend Aristocrat Stocks To Buy Now
September 25, 2023 | finance.yahoo.com
These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
September 21, 2023 | marketwatch.com
Medtronic PLC stock outperforms competitors despite losses on the day
September 21, 2023 | finance.yahoo.com
Why Is Medtronic (MDT) Down 2.6% Since Last Earnings Report?
September 21, 2023 | finance.yahoo.com
Medtronic Diabetes announces CE Mark for new Simplera™ CGM with disposable all-in-one design
September 21, 2023 | finance.yahoo.com
Tim Herbert Gave A Breath Of Fresh Air To Sleep Apnea Patients
September 21, 2023 | finance.yahoo.com
Medtronic PLC (MDT): A Deep Dive into Its Dividend Performance and Sustainability
September 20, 2023 | news.yahoo.com
Medtronic may invest $133M in Memphis facility with 265 new jobs
September 20, 2023 | finance.yahoo.com
Medtronic plc (NYSE:MDT) Stock's On A Decline: Are Poor Fundamentals The Cause?
September 19, 2023 | finance.yahoo.com
Medtronic LABS Unveils Commitment To Scale Tech-Enabled Healthcare at Clinton Global Initiative 2023 Meeting
September 19, 2023 | nasdaq.com
2 Beaten-Down Dividend Growth Stocks That Look Like Bargains Now
September 19, 2023 | finance.yahoo.com
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients
September 13, 2023 | seekingalpha.com
Medtronic plc (MDT) CEO Geoff Martha Presents at Bank of America Global Healthcare Conference (Transcript)
See More Headlines
Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Company Calendar

Ex-Dividend for 7/14 Dividend
6/22/2023
Dividend Payable
7/14/2023
Last Earnings
8/22/2023
Ex-Dividend for 10/13 Dividend
9/21/2023
Today
9/29/2023
Dividend Payable
10/13/2023
Next Earnings (Estimated)
11/28/2023
Fiscal Year End
4/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:MDT
CUSIP
58505510
CIK
1613103
Web
www.medtronic.com
Phone
(531) 438-1700
Fax
763-514-4879
Employees
95,000
Year Founded
1949

Price Target and Rating

Average Stock Price Forecast
$91.67
High Stock Price Forecast
$106.00
Low Stock Price Forecast
$80.00
Forecasted Upside/Downside
+16.8%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
14 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$2.71
Trailing P/E Ratio
28.97
Forward P/E Ratio
15.33
P/E Growth
2.75
Net Income
$3.76 billion
Net Margins
11.47%
Pretax Margin
17.48%
Return on Equity
13.81%
Return on Assets
7.74%

Debt

Debt-to-Equity Ratio
0.48
Current Ratio
2.42
Quick Ratio
1.79

Sales & Book Value

Annual Sales
$31.23 billion
Price / Sales
3.34
Cash Flow
$7.35 per share
Price / Cash Flow
10.68
Book Value
$38.61 per share
Price / Book
2.03

Miscellaneous

Outstanding Shares
1,330,530,000
Free Float
1,326,542,000
Market Cap
$104.45 billion
Optionable
Optionable
Beta
0.71

Social Links

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Geoffrey Straub Martha (Age 53)
    Chairman & CEO
    Comp: $1.79M
  • Ms. Karen L. ParkhillMs. Karen L. Parkhill (Age 58)
    Exec. VP & CFO
    Comp: $992.24k
  • Mr. Sean M. SalmonMr. Sean M. Salmon (Age 58)
    Exec. VP & Pres of Cardiovascular Portfolio
    Comp: $900.97k
  • Mr. Robert J. W. ten Hoedt (Age 63)
    Exec. VP & Pres of Global Regions
    Comp: $1.24M
  • Mr. Robert John WhiteMr. Robert John White (Age 60)
    Exec. VP & Pres of Medical Surgical Portfolio
    Comp: $925.22k
  • Mr. Mark Ploof
    Sr. VP of Global Operations and Bus. Services
  • Ms. Jennifer M. Kirk (Age 48)
    Sr. VP, Global Controller & Chief Accounting Officer
  • Dr. Kenneth E. Washington Ph.D. (Age 63)
    Sr. VP and Chief Technology & Innovation Officer
  • Dr. Laura Mauri M.D.
    M.Sc., Sr. VP and Chief Scientific, Medical & Regulatory Officer
  • Mr. Ryan Weispfenning
    VP & Head of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













MDT Stock - Frequently Asked Questions

Should I buy or sell Medtronic stock right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
View MDT analyst ratings or view top-rated stocks.

What is Medtronic's stock price forecast for 2023?

14 equities research analysts have issued 1-year target prices for Medtronic's shares. Their MDT share price forecasts range from $80.00 to $106.00. On average, they predict the company's share price to reach $91.67 in the next year. This suggests a possible upside of 16.8% from the stock's current price.
View analysts price targets for MDT or view top-rated stocks among Wall Street analysts.

How have MDT shares performed in 2023?

Medtronic's stock was trading at $77.72 at the beginning of the year. Since then, MDT stock has increased by 1.0% and is now trading at $78.50.
View the best growth stocks for 2023 here.

When is Medtronic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 28th 2023.
View our MDT earnings forecast.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) posted its quarterly earnings results on Tuesday, August, 22nd. The medical technology company reported $1.20 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.09. The medical technology company earned $7.70 billion during the quarter, compared to analysts' expectations of $7.57 billion. Medtronic had a trailing twelve-month return on equity of 13.81% and a net margin of 11.47%. The business's revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.13 earnings per share.
Read the conference call transcript.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Thursday, August 17th. Shareholders of record on Friday, September 22nd will be paid a dividend of $0.69 per share on Friday, October 13th. This represents a $2.76 dividend on an annualized basis and a dividend yield of 3.52%. The ex-dividend date is Thursday, September 21st.
Read our dividend analysis for MDT.

What ETFs hold Medtronic's stock?

ETFs with the largest weight of Medtronic (NYSE:MDT) stock in their portfolio include iShares U.S. Medical Devices ETF (IHI), Simplify Health Care ETF (PINK), American CenturyFocused Large Cap Value ETF (FLV), Leatherback Long/Short Alternative Yield ETF (LBAY), Absolute Select Value ETF (ABEQ), Cambiar Aggressive Value ETF (CAMX), WisdomTree U.S. AI Enhanced Value Fund (AIVL) and Global X Aging Population ETF (AGNG).

Is Medtronic a good dividend stock?

Medtronic (NYSE:MDT) pays an annual dividend of $2.76 per share and currently has a dividend yield of 3.53%. The company has been increasing its dividend for 47 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 101.85%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MDT will have a dividend payout ratio of 50.55% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDT.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its FY 2024 earnings guidance on Tuesday, August, 22nd. The company provided earnings per share (EPS) guidance of $5.08-$5.16 for the period, compared to the consensus estimate of $5.05. The company issued revenue guidance of $32.09 billion-$32.09 billion, compared to the consensus revenue estimate of $32.18 billion.

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

How do I buy shares of Medtronic?

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $78.50.

How much money does Medtronic make?

Medtronic (NYSE:MDT) has a market capitalization of $104.45 billion and generates $31.23 billion in revenue each year. The medical technology company earns $3.76 billion in net income (profit) each year or $2.71 on an earnings per share basis.

How many employees does Medtronic have?

The company employs 95,000 workers across the globe.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for the company is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879.

This page (NYSE:MDT) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -